Vietstar Biomedical Research

Executive Summary

Vietstar Biomedical Research is a Vietnam-based Contract Research Organization (CRO) offering full-service clinical development solutions from Phase I to Phase IV. Founded in 2020 and headquartered in Hanoi, the company leverages a team of experienced professionals from leading international CROs to provide trial design, site selection, regulatory support, data management, medical writing, and quality assurance. Its therapeutic focus includes hypertension, oncology, infectious diseases, diabetes, and other key areas. By combining local expertise with global standards, Vietstar aims to serve both domestic and international pharmaceutical sponsors, positioning itself as a cost-effective and high-quality partner for clinical trials in Southeast Asia. The company's growth is driven by the increasing outsourcing of clinical research to emerging markets and Vietnam's favorable regulatory environment.

Upcoming Catalysts (preview)

• TBDNew contract wins from global pharma sponsors70% success
• TBDExpansion of service offerings into new therapeutic areas60% success
• TBDPotential strategic partnership or investment for regional expansion50% success